








































Most old-age perils, such as neurodegenerative, 
cardiovascular, and metabolic diseases, are 
accompanied by physiologic decline determined by the 
derailment of underlying molecular signaling networks 
at the cellular level. Cerebral aging is accompanied by a 
loss of synaptic contacts and neuronal apoptosis, 
leading to changes in cognitive function. The aging 
process and the related dysfunction are compounded by 
the combination of oxidative, metabolic and excitotoxic 
stress [1]. The oxidative stress may also be involved in 
mitochondrially mediated apoptotic pathways, accu-
mulating  calcium  in  aged  neurons  [2-5].  Age-related 
 
 






































changes in the expression of genes involved in energy 
metabolism, oxidative stress, and innate immunity are 
counteracted by calorie restriction (CR) [6]. CR has an 
established neuroprotective role in the brain by up-
regulating anti-apoptotic regulatory proteins that may 
prevent neuronal death [7]. Both CR-fed and genetically 
modified dwarf mouse brains manifest a significant 
delay in aging, and improved cognitive function [8]. As 
the molecular mechanisms involved may not be 
completely similar in CR-fed and genetically modified 
mice, detailing the post-transcriptional regulation of 
genes involved in CR-affected signaling pathways 
should facilitate the decoding of the divergence between 
these two means of extending longevity and cognitive 
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microRNAs suppressing unwanted gene expressions 
and down-regulated microRNAs whose targets genes 
are important for cellular function has been noted with 
regard to the normal aging process in brain [10]. These 
findings suggest that the caloric restriction-derived gain 
of cognitive robustness may be due to the absence, 
reduction and/or delay of this imbalance paradigm.   
Here we report that this is indeed the case; in particular, 
our results show that three microRNAs (miRNAs), 
mmu-miR-181a-1*, mmu-miR-30e and mmu-miR-34a, 
show no age-dependent up-regulation in CR animals, 
seen in ad lib-fed controls, nor reciprocal up-regulation 
of their target, the Bcl-2 gene. The down-regulation of 
these three miRNAs was initially identified by array 
screening, and validated by RT-PCR and in situ 
hybridization profiling in brains of older, CR-fed mice, 
compared to their ad lib-fed littermates. Parallel protein 
profiling shows an age-dependent increase of Bcl-2 in 
brains of older calorie-restricted mice. Functionally, all 
three microRNAs are capable of repressing the reporter 
expression of Bcl-2 3’UTR construct; the transfected 
cells are shown to lose this pro-survival gene and gain 
pro-apoptosis gene expression, with increased death 
rates in both mouse and human cell culture models. 
 
In summary, our data suggest that caloric restriction 
may induce the loss of age- dependent increase of key 
miRNAs, and this loss may in turn permit Bcl-2 to 
remain elevated in the brains of older, CR-fed animals, 
resulting in the loss of pro-apoptosis signaling and gain 
of neuronal survival. Thus, loss of deleterious up-
regulation of these miRNAs may be the underlying 
mechanism contributing in part to the gain of robustness 
in CR-fed mice. 
 
MiRNA expression targeting Bcl-2 in calorie-
restricted mouse brain 
 
The comparative expression of the miRNAs of interest 
was screened by miRNA microarrays (MMChips) in 
brain samples of CR- and ad lib-fed mice.  The brain 
tissues were obtained from the National Institute on 
Aging tissue bank; C57/black 6 mice were calorie- 
restricted to 60% of normal ad lib caloric intake, 
according to the standardized regimen, starting at 4 
months of age.  By 12 months of age, the CR impact is 
fully established; therefore this age group was selected 
along with two older groups, 24 and 28 months 
(Supplementary Figure 1A). For each group, total RNA 
from brain tissues of three mice was used, to control for 
inter-animal variations.  In addition, three MMChips 
were used for each mouse brain RNA sample, to 
generate statistically significant results of 9 datasets per 
age group.  The Significance Analysis of  Microarray 
(SAM) software listed miRNAs showing significant 
change (Figure 1A). MicroRNAs exhibit variations in 
expression in CR-fed mouse brain tissues, compared to 
their ad lib-fed counterparts, with inverse expression of 
age-dependent patterns (Figure 1A). 
 
Among these, three microRNAs, mmu-mir-181a-1*, 
mmu-mir-34a and mmu-mir-30e, exhibit the most 
significant down-regulation in brains of CR-fed mice, in 
an age-dependent manner, compared to ad lib-fed mice 
(Figure 1B). The expression profiles of these three 
microRNAs were further confirmed by quantitative 
real-time PCR (qRT-PCR) (Figure 1B). These three 
miRNAs were selected because they manifest correlated 
fold changes at 24 and 28 months between CR- and ad 
lib-fed mice. All three microRNAs display significantly 
decreased expression in CR-fed mice at 28 months of 
age, compared to ad lib-fed mice. A disparity exists 
between MMChip results and qPCR in miR-30e 
expression, when 24 month old CR-fed mice are 
compared to 24 month old ad lib-fed control mice; the 
array results show decreased expression, whereas qPCR 
results show increased expression in 24-month CR-fed 
mice (Figure 1B). The qPCR data also show a 
significant difference in miR-34a expression between 
CR- and ad lib-fed mice at 28 months of age, whereas 
array data point to almost similar expression levels at 
that age. These anomalies seem to be based on the fact 
that microarray screening is less sensitive, and the 
analyses are based on signal strength from hundreds of 
loci on the arrays. Even after normalization with 
negative and positive controls, the assay is less sensitive 
than qPCR assay, which quantifies a single miRNA at a 
given time. Interestingly, a common denominator among 
all these three miRNAs is the age-dependent decrease in 
expression in CR-fed compared to ad lib-fed mice. 
 
The miRBase targets version 5 database 
(http://microrna.sanger.ac.uk/) reported a set of nine 
genes which are targeted by all three miRNAs (Figure 
1B); three other databases were employed to further 
confirm the predicted relationship between these 
miRNAs and these target genes. Bcl-2 was a consistent 
result from all the databases (Target Scan, Pictar and 
RNA 22). This analysis pointed to the fact that even 
human Bcl-2 may be a target for these miRNAs, as the 
seed sequences of these three miRNAs are well 
conserved between mice and humans (data not shown). 
In ad lib-fed mouse brain tissues Bcl-2 expression levels 
show an age- dependent decline (Figure 1C). In CR brain 
tissues, Bcl-2 expression is not only maintained, but 
rather increases as the mice reach the advance age of 28 
months. This persistent increase in expression levels with 
age is inversely related to the reduced expression of 
miRNAs at the age of 28 months (Figure 1C). 
   











































We further analyzed the number of target sites for these 
miRNAs on the 3’ UTR regions of the predicted target 
genes. Based on these exercises of algorithmic 
prediction, the 3’UTR of Bcl-2 and binding sites of the 
three miRNAs are depicted in the schematic diagram 
(Figure 1D). 
 
In situ detection of miRNAs and Bcl-2 in calorie-
restricted mouse brain tissues 
 
MicroRNA -181a-1*,-34a and -30e expression patterns 












































determined by in situ hybridization (ISH), using LNA 
(locked nucleic acid) probes (Figure 2A), in coronal 
serial sections of 10 μm thickness from 12, 24 and 28 
month old brains. The densitometry values from the 
acquired images were normalized with the values from 
a hybridization control where a scrambled LNA probe 
was used. The expression profiles were consistent with 
our array screening and qPCR validation results. All 
three miRNAs showed reduced staining intensity in CR-
fed mouse brains, compared to ad lib-fed mice; this 
difference was seen not only in cortical, but also in 






















































The predicted target for these miRNAs, Bcl-2 
expression, was detected by immunohistochemistry, as 
described in Methods. Increased staining of Bcl-2 was 
observed in CR-fed, compared to ad lib-fed, mice, in an 
age-dependent manner (Figure 2B). Densitometry 
values from the acquired images were normalized with 
values from a blank control (picture not shown).   
Cortical and hippocampal regions evenly show the 
elevated expression of Bcl-2 in CR- fed mice, in an age-
dependent manner. Taken together, the correlated 
inverse expression of these miRNAs and Bcl-2 was 
validated by in situ hybridization and immuno-











































MiRNA-dependent down-regulation of Bcl-2 in 
human and mouse cells 
 
To evaluate the repression of Bcl2 by any of the three 
microRNAs, we used transfection to over-express miR-
34a, -30e, or -181a in human embryonic kidney cells 
(HEK-293 cells) and mouse fibroblast cells (NIH/3T3 
cells).  The fact that miRNA binding sites on the 3’UTR 
region of Bcl-2 are conserved between mice and men 
gave us the opportunity to test this relationship in a 
mouse-independent system.  Our results show that 
indeed Bcl-2 expression is repressed in all three 
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body to this protein (Figure 3A-B).  The densitometry 
values from the acquired images provide quantitative 
indices for this repression effect, plotted as histograms 
of miRNA expression in relationship to the repressed 
level of Bcl2 in these transfected cells. 
 
MiRNAs effect Bcl-2/Bax ratio favoring pro-survival 
signaling 
 
Since Bcl-2 is an anti-apoptotic, and Bax a pro-
apoptotic, gene, their ratio is a profound indicator of 
cell survival; this survival ratio can be altered either by 
increased Bcl-2 expression or decreased Bax 
expression. In CR-fed mice the Bcl-2/Bax ratio showed 
an increased trend in an age-dependent manner, 
compared to ad lib-fed mice (Figure 4A). To validate 
this antagonistic pattern between Bcl2 and Bax protein 
levels, we examined their ratios in microRNA-
transfected HEK-293 and NIH/3T3 cultures.  Total 
cellular protein fractions were isolated, as described in 
Methods. Decreased expression of Bcl-2 in miRNA-
transfected cultures indeed led to a decline in Bcl-2/Bax 
ratio (Figure 4 B-C); densitometry values from the 






























values from alpha-tubulin blots as the loading control.  
Taken together, each of these three miRNAs is able to 
repress Bcl-2 in transfected cells, with subsequent 
increase of Bax proteins, thus resulting in a reduced 
Bcl2/Bax ratio.  Finally, these results provide validation 
that Bcl-2 is a shared target for silencing by all three 
miRNAs at the post-transcriptional level.  
  
Altered expression of apoptosome-specific proteins 
Caspase-9 and Caspase-3 
 
To validate the effect of Bcl-2 on apoptosome-mediated 
apoptosis, we examined the expression of Caspase-9 and 
Caspase-3. In line with Bcl-2 expression, the expression 
of cleaved Caspase-9 and Caspase-3 is significantly 
reduced in age-dependent manner from young to old age 
groups in CR-fed, compared to ad lib-fed, mouse brain 
samples (Figure 5A). Western blot assays were done 
using brain tissue samples from three different animals 
from CR- and ad lib- fed mice from each age group. For 
Western blot, in situ and qPCR assays, the specimens 
used were from the same mice, to maintain homogeneity 
and avoid inter-animal variation. The level of α-tubulin 
expression was used as the internal control for 

















































MiRNA-mediated repression of Bcl-2 3’UTR and 
elevated apoptosis in cell lines 
 
To address the cascade effect from over-expression of the 
three microRNAs to repress Bcl-2 expression, with 
subsequent increase of Bax and downstream 
corresponding increase in Caspase activities, the miRNA-
transfected HEK-293 and NIH/3T3 cultures were further 
examined by Western blot analysis with antibodies to 
Caspases, whose autocatalytic cleavage is essential to 
execute apoptotic death. Our results show that in 
transfected cells, the decreased Bcl-2/Bax ratio is 
accompanied by a significant increase in cleaved 
Caspase-9 and Caspase-3 (Figure 5B).  Further validation 









































induce the chain reaction of an increase in Bax and 
Caspase cleavage, was achieved by direct repression 
assays with co-transfection experiments, where miR-34a, 
-30e, or 181a-1* expression plasmids were used to co-
transfect along with cloned 3’-UTR reporter construct in 
HEK-293 cells. At 72 hours, the green fluorescence 
corresponding to the miRNA constructs can be observed, 
with fading red fluorescence of the reporter expression of 
3’UTR constructs, compared to co-transfection 
experiments using control vector carrying a scrambled 
sequence. Image analysis of the intensities between the 
miR-plasmid and reporter constructs was performed; 
repression of the Bcl-2 3’UTR reporter intensities was 
significant in the miR-plasmid co-transfected cells, but 































































































































the  apoptosome  complex.  (A)  In  calorie‐restricted  (CR)‐fed  mouse  brain  tissues,  levels  of  c‐Caspase‐9  and ‐ 3  decline  in  an  age‐
dependent manner, compared to Ad Lib (AL)‐fed mice. (B) Over‐expression of three miRNAs in HEK‐293 and NIH/3t3 cells produces a






































Further functional impact of these miRNAs’ repression 
of bcl2 expression was performed by examining 
putative increases of apoptotic death in the transfected 
cells. MiRNA- transfected HEK-293 and NIH/3T3 cells 
were subjected to apoptosis inducers such as 
staurosporine, a general protein kinase inhibitor isolated 
from the bacterium Streptomyces staurosporeus.  Our 
results show that indeed transfected cells show dosage-
dependent decrease in LD50.  Since the transfection 
assays rarely acquire 100% efficiency, cell death 
percentages were calculated based on the positively 
transfected cell number, rather than the total cells in the 
cultures; the increase of apoptosis in cells with 
transduced microRNA expression indeed corresponds to 
the decrease of LD50 indices. 
    
 Taken together, our work has shown that: during aging, 
miR-34a, -30e, and -181* are not up-regulated in CR 
brain, while pro-survival gene Bcl-2 is maintained at the 




































accompanied by a decrease of pro-apoptosome proteins 
such as Bax and Caspase 9 cleaved products. Functional 
validation of the three microRNAs’ silencing effect on 
Bcl-2, with subsequent induction of pro-cell death 
signaling, was documented by transfection studies, and 
suggests the role of these miRNAs in apoptosis.  Thus, 
during aging, down-regulation of the three microRNAs 
may indeed reflect a gain of survival signaling in 




In the present study, our data report that lead 
microRNAs (mmu-miR-181a-1*, mmu-miR-30e and 
mmu-miR-34a) are not up-regulated in the older CR 
mouse brain, compared with their ad lib counterparts.  
This corresponds to Bcl-2 expression maintaining at a 
high level, and down-regulated proteins of apoptosome 
formation.  Functional assays show that indeed the three 
miRNAs can  repress  Bcl-2 and increase  pro-apoptosis  
   









 gene expression and cell death. The CR regimen seems 
to ablate the ill effects of aging by down-regulating 
these miRNAs in an age- dependent manner. Most 
interestingly, our results demonstrate that not only one, 
but three microRNAs targeting the pro-survival gene, 
Bcl-2, are all down-regulated in older CR brains. This 
suggests that the caloric restriction regimen may affect 
the group dynamics of the three microRNAs in unison, 
and the ablation of their up-regulation could be the 
pivotal post-transcriptional regulation to reduce the 
trend of increased cell death in brain during aging.   
Down-regulated miR-34a, -30e, and -181a-1*, together 
then not only provide neuronal biomarkers for the CR 
brain, but also their impact on the shared target, Bcl-2, 
may be the cornerstone to unravel the complex 
pathways involved in neuronal survival signaling.  
  
Apoptosis suits itself into antagonistic pleiotropy theory 
and as it has deleterious effects in aging neurons while 
it is needed during development where it removes 
neurons that don’t integrate into the growing neuronal 
network [11]. However, after the development of the 
neuronal network into the mature nervous system, the 
fight of neurons for survival and healthy existence with 
plasticity becomes anti-apoptotic [12]. In the 
mitochondrial pathway of apoptosis, intracellular 
signals result in releasing cytochrome c from mito-




























(apoptotic protease-activating factor-1), which further 
leads to the activation of Caspase 9 and subsequently 
Caspase 3; these are the proteases responsible for 
disintegration of the cell,  Figure 7 and  [13, 14].  Our 
results suggest a post-transcriptional paradigm by CR 
regimen for down-regulation of three vital microRNAs, 
miR-34a, -30e, and -181a, with consequential loss of 
Bcl-2 repression and downstream Bax/Caspase 
decrease, a scenario favoring neuronal survival.  The 
cascade effect of the decrease of the three microRNA 
expressions in the CR-treated mouse brain is Bcl-2 not 
showing the usual age-dependent decrease, with 
decreased Bax expression and Caspase activity.  This 
microRNA-directed impact on survival signaling is due 
to the fact that Bcl-2 as a pro-survival gene is a member 
of the anti-apoptotic group, which binds to and inhibits 
the action of multi-domain pro-apoptotic proteins like 
Bax [15]. Moreover, the up-regulation of Bcl-2 
expression leads to down-regulation of Bax, and 
interferes with the release of cytochrome c from the 
mitochondrial intermembrane space into the cytosol, 
where it associates with Caspase 9 and Apaf1 to form 
the apoptosome complex, thus effecting apoptosis [16, 
17].  Figure 6 C elucidates the role of elevated Bcl-2 
expression because of the decline in these three miRNAs’ 
expression in CR-fed mouse brain tissues. This increase 
in Bcl-2 expression leads to altered survival signaling, 
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associated with increasec neuronal apoptosis, as one 
mechanism contributing to cognitive dysfunctions [18-
21]. Caspase 3 and Bax up-regulation has been observed 
in patient samples and in classic animal 
neurodegenerative models such as stroke, AD 
(Alzheimer's disease), HD (Huntington's disease) and PD 
(Parkinson's disease) [22, 23].The Bcl-2 protein resides 
in the outer mitochondrial wall, and acts as an anti-
apoptotic factor by controlling mitochondrial 
permeability, thus regulating apoptosis [24]. More 
evidence of the interplay of Bcl-2 and Bax in these 
diseases comes from the increased neuronal survival in 
mouse models that either have Bcl-2 over-expression or 
Bax knockout [25-30]. Bcl-2 is known to protect neurons 
against Ca2+-mediated death [31]. Previous evidence of 
miRNA impact on cell survival mechanisms has been 
shown with miR-15 and miR-16 targeting Bcl-2 mRNA 
and inducing apoptosis [32, 33]. Therefore the down-
regulation of miRNAs that target pro-survival genes may 
be interpreted as potential therapeutic candidates for 
preventing apoptotic death in neuronal cells, thus 
contributing to cognitive robustness. Little is known as to 
how post-transcriptional regulation of cellular signaling 
underlies the mechanism of the CR impact on extended 
life span.  Our present work is an early example of how 
non-coding RNAs such as microRNA can modulate key 
gene expression, specifically the absence of the normal 
up-regulation of key microRNA expression.  This 
absence indirectly results in the presence of genes whose 
function is essential to maintain the wellness of neurons.  
The example of the down-regulation of three lead 
microRNAs, with the corresponding maintenance of pro-
survival genes and the cascade effect leading to the lack 
of apoptosis-inducing factors, opens the door to a fertile 
ground of discovery of CR impact on post-transcriptional 
modification.  
 
Mechanistically, expression of non-coding RNAs such 
as microRNA follows molecular regulation like that of 
coding genes, involving binding of a transcriptional 
factor (TF) to a promoter region for the specific miRNA 
to be transcribed, with feed-forward and feed-back loop 
modulation,  etc.  Intervention by caloric restriction 
probably induces putative crucial TF/miR activation, 
with complex biochemical regulation [10].  Obviously, 
identification of TFs responsible for the activation of 
these three microRNAs, miR-34a, -30e, and -181a, will 
be an essential first step in our quest for the impact of 
CR on their down-regulation.  Success of this 
approach will open the possibility that CR mimetics 
could be developed, so as to endow wild-type ad lib-
fed animals with the same benefits of not having these 
microRNAs up-regulated.  Future work in this 
direction will provides leads such that intervention in 
the later stages of life may be approached by post-
transcriptional modification of unwanted microRNA 
up-regulation.  Thus, pro-survival Bcl-2 expression 
would be maintained at its optimal level, reducing 





For comparative proteomic and miRNA expression 
analysis, 18 mice were divided equally into CR and AL 
populations across 3 age groups: 12, 24 and 28 months. 
All experiments were carried out in triplicate.  
 
MicroRNA profiling. Small RNA samples (1 µg) were 
labeled with digoxigenin (DIG) using the DIG 
Oligonucleotide Tailing Kit, 2nd Generation (Roche 
Diagnostics, U.S.A.) as described earlier [34]. Our own 
mouse miRNA DNA nitrocellulose membrane 
microchips (MMChips) were printed bearing 367 anti-
sense mature miRNA sequences from miRBAse 
(http://microrna.sanger.ac.uk/Version 8.2) as previously 
described [35]. The membranes were scanned by an 
Expression 1680 scanner (Epson, U.S.A.), and data was 
acquired using Array-Pro Analyzer 4.5 software (Media 
Cybernetics, MD, U.S.A). Net intensity was derived 
from whole cell area measurement, and corrected using 
mean intensity of ring background of surrounding spots. 
Microarray data analyses were performed with SAM 
software, version 3.02 (Significance Analysis of 
Microarrays, Stanford University, CA), including 
pairwise comparison (T statistics) between age groups. 
Kolmogorov-Smirnov statistics were generated by Gene 
Set Enrichment Analysis (GSEA) software [36]. 
 
Mouse tissue samples. Tissue samples were obtained 
from the National Institute of Aging 
(http://www.nia.nih.gov/ResearchInformation/Scientific
Resources/AgedRodentTissueBankHandbook/RodentTi
ssueBankResourcesInfo.htm) from CR- and AL-fed 
mice, at age groups of 4, 12, 24, and 28 months. The 
tissue samples were rapidly frozen at −80°C for 
analysis. Tissue samples were processed for protein, 
RNA extraction and in situ experiments as described 
below. Animal tissue related processing and 
experiments were done in accordance to the approved 
institutional (University of Louisville) biosafety board 
protocol #05-001. 
 
Total and small RNA extractions. For total RNA 
extraction, the frozen tissue blocks were homogenized 
with Trizol according to the manufacturer’s 
instructions.  Small RNA enrichment was done using 
incubation with PEG 8000, as described previously 
[37].  
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homogenized in two volumes (g mL−1) of RIPA buffer 
(150 mm NaCl, 10 mm Tris, pH 7.2, 0.1% SDS, 1.0% 
Triton X-100, 1% deoxycholate, 5 mm EDTA, pH 8.0) 
containing 1× protease inhibitor (Calbiochem, San 
Diego, CA) and centrifuged at 10,000 × g for 10 min. 
The supernatant containing the proteins was harvested. 
The Bradford method was used to quantify total protein 
concentration with BioRad reagents (BioRad, Hercules, 
CA). 
 
QRT-PCR validation. Quantitative real-time PCR was 
carried out using Taqman miRNA assay reagents to 
verify miRNA expression profiles. Two hundred 
nanograms of total RNA were reverse transcribed to 
cDNA; the real-time PCR reactions were performed on 
a 7500 Fast System Real-Time PCR cycler (Applied 
Biosystems, Foster City, CA), according to the 
manufacturer’s instructions. MicroRNA expression fold 
changes between ages across the groups were calculated 
using the delta Ct method, using RNU44 for 
normalization. 
 
Western Blotting. The brain tissues (12, 24, 28 month 
ad lib- and CR-fed mice, n=3 each) were homogenized 
as described previously [34].Following this procedure, 
membranes were incubated overnight at 4°C with 
primary antibodies: rabbit anti-Bcl-2, rabbit anti-Bax, 
rabbit anti-Caspase-3 and rabbit anti-Caspase-8 
antibodies (sc-783, sc-6236, sc-7148 and sc-7890; Santa 
Cruz Biotechnology Inc, Santa Cruz, CA) and rabbit 
anti-Caspase-9 antibody (ab32539; Abcam Inc., 
Cambridge, MA). Blots were developed as described 
before [34]. 
 
Tissue processing for in situ hybridization and 
immunohistochemistry. The frozen brain tissue blocks 
were prepared by placing them in a cutting mold on dry 
ice, covered with Optimal Cutting Temperature 
(O.C.T.) compound (Sakura, Torrance, CA). The blocks 
were kept at -80 °C overnight; then10 µm sections were 
collected in the coronal plane by cryostat (Leica, Solms, 
Germany), and mounted onto Superfrost
®Plus 
microscopic slides (Fisher Scientific, Pittsburgh, PA). 
Slides were stored at −80°C until further use. 
 
MicroRNAs locked nucleic acid (LNA) in situ 
hybridization. The frozen sections were fixed with 4 % 
paraformaldehyde (PFA) for 30 min at room 
temperature, washed in 0.1 M phosphate-buffered saline 
(PBS) for 20 min, and treated with acetylation solution 
(92.8 % diethylpyrocarbonate (DEPC)-treated water, 1.3 
% triethanolamine, 0.2 % HCl, 5.7 % acetic acid) for 20 
min. The in situ hybridization was performed for miR-
34a, miR-30e and 181a-1* as described previously [34]. 
Immunohistochemistry. The sections were then blocked 
with 10 % goat serum for 30 minutes (Invitrogen, 
Carlsbad, CA), and incubated with rabbit anti-Bcl-2 
antibody (sc-783; Santa Cruz Biotechnology Inc, Santa 
Cruz, CA) overnight at 4°C. After incubation, the 
sections were washed thrice with PBS for 5 minutes, 
and incubated with Alexa fluor 555 goat anti-rabbit IgG 
(#4413; Cell Signaling Technology, Inc., Danvers, 
MA). For signal detection and analysis the procedure 
was followed as described earlier [34].  
 
Construction of Bcl-2 3'-UTR Reporter Construct and 
miRNA expression constructs. Mouse Bcl-2 full length 
3’-UTR was cloned into ptdTomato-C1 vector from 
Clontech (Mountain View, CA), following the gap 
repair method [38]. Briefly, upstream and downstream 
miniarms were amplified from mouse C57BL/6J 
genomic DNA using the following primers. The retrieve 
construct was made by cloning these two miniarms into 
EcoRI plus BamHI linearized ptdTomato-C1, following 
the Circular Polymerase Extension Cloning method 
[39]. After sequencing verification, the retrieve 
construct was linearized with EcoRV and electroporated 
into recombineering-competent bacterial artificial 
chromosome (BAC) clone containing the Bcl-2 3'-UTR 
genomic sequence. The BAC clone was made 
recombineering-competent  by transformation with 
pKD46 [40]. Bcl-2 3'-UTR in ptdTomato-C1 was 
selected by kanamycin resistance, and verified by full 
coverage sequencing. 
 
Expression constructs of mouse miR-34a, -30e, -181a, 
and miR-93 over were made by cloning miRNA 
precursor sequences with a flanking genomic sequence 
amplified from mouse genomic DNA (C57BL/6J) into 
pCDH-CMV-MCS-EF1-copGFP vector (System 
Biosciences, Mountain View, CA). The primers used 








and mmu-miR-181a-Rev: TCGGGTCCTGCTTTGCGG 
TT. The miRNA expression constructs were grown in 
Stbl3 strain (Invitrogen, Carlsbad, CA). 
 
Cell transfection/co-transfection studies. Human 
embryonic kidney (HEK) 293 cells and NIH/3T3 cells 
(ATCC, Manassas, VA) were used for transfection/co-
transfection experiments with the cell line nucleofector 
kit V by Nucleofector System (Lonza Walkersville Inc., 
Walkersville, MD), according to the manufacturer's 
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6 cells were suspended in 
100 μL nucleofector solution, and transfected with 5 
μg of plasmids (vector control, scrambled control, 
mmu-miR-34a, mmu-miR-30e or mmu-miR-181a-1*). 
For co-transfection, the Bcl-2 3’UTR construct was 
co-transfected with vector alone, scrambled control, 
miR-34a, miR-30e and miR-181a-1* (1:1 ratio). The 
procedure followed has been described previously 
[34]. 
 
Apoptosis Assay. Human embryonic kidney (HEK) 293 
cells and NIH/3T3 cells (ATCC, Manassas, VA) were 
used for transfection/co-transfection experiments with 
the cell line nucleofector kit V from Nucleofector 
System (Lonza Walkersville Inc. Walkersville, MD) 
according to the manufacturer's instructions. MiRNA 
expression plasmids were transfected, and transfection 
efficiency was calculated. Various doses of 
Staurosporine (2nM to 10nM) were used, and LD50 was 
calculated based on the cell death ratios in miRNA-
transfected and their respective control transfected cells. 
LD50 doses for miRNA transfected cells were calculated 
to determine the effect of miRNA on cell survival. Cells 
were stained with Tryphan blue as per the 
manufacturer’s instructions (http://cellgro.com/). 
 
Statistical analysis. All tests were performed using 
SPSS Professional Edition software (IBM). Descriptive 
statistics including mean and s.e.m. along with one-way 
ANOVAs followed by multiple comparison tests and 
two tailed T test were used to determine significant 
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Supplementary Figure 1. Minimal change in miRNA expression between 4 and 12 months, and shared targets
of miRNAs. (A) Fold changes between CR‐fed mouse brain tissues at 12 months and littermates at 4 months are identical. As
the dietary regimen was started at 4 months, insignificant change in these three miRNA expressions signifies that the effect of
CR becomes evident later in life. (B) All three miRNAs share nine targets, based on bioinformatics (RNA22 program), signifying
the ‘pack‐hunting’ role in which multiple miRNAs target single genes to manipulate crucial cellular mechanisms.  